Back to Search
Start Over
The Food and Drug Administration Office of Women's Health: impact of science on regulatory policy.
- Source :
-
Journal of women's health (2002) [J Womens Health (Larchmt)] 2007 Jul-Aug; Vol. 16 (6), pp. 807-17. - Publication Year :
- 2007
-
Abstract
- In 1994, the Food and Drug Administration Office of Women's Health (FDA-OWH) was created to provide leadership and policy direction for the Agency regarding issues of women's health. Within its first year, the FDA-OWH established a science program for women's health research, promoting the development of sound policy and regulation. In a little over a decade, the program has provided approximately 14 million dollars to fund more than 100 women's health research studies covering a broad range of health topics affecting women across their lifespan. Some studies, such as those elucidating drug effects on QT prolongation in women and drug-dietary supplement interaction, have had significant influence on regulatory decisions. Other studies have provided sound scientific data on sex and gender differences supporting FDA guidelines to protect women's health. This paper describes the science program at the FDA-OWH, providing examples of how funded research impacts regulatory policy.
- Subjects :
- Adverse Drug Reaction Reporting Systems legislation & jurisprudence
Budgets
Female
Health Policy economics
Health Policy trends
Humans
Leadership
Policy Making
Research economics
United States
United States Food and Drug Administration organization & administration
Health Policy legislation & jurisprudence
Research legislation & jurisprudence
United States Food and Drug Administration economics
Women's Health
Subjects
Details
- Language :
- English
- ISSN :
- 1540-9996
- Volume :
- 16
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Journal of women's health (2002)
- Publication Type :
- Academic Journal
- Accession number :
- 17678451
- Full Text :
- https://doi.org/10.1089/jwh.2006.0135